99 results
PRE 14A
AKRO
Akero Therapeutics Inc
16 Apr 24
Preliminary proxy
4:30pm
Stockholders
Report of the Audit Committee
Householding
Stockholder Proposals
Other Matters
Appendix A
AKERO THERAPEUTICS, INC.
601 Gateway Boulevard … to ratify the appointment by the audit committee of the board of directors of Deloitte & Touche LLP as Akero’s independent registered public accounting firm
8-K
EX-1.1
1eqyz4ueof7ooo4 dsu
6 Mar 24
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-1.1
lqd6a j55p8b664ixwnp
17 May 23
Akero Therapeutics Announces Pricing of $220.0 Million Underwritten Offering of Common Stock
5:01pm